Rocket Lab (RKLB) is back in focus after securing a US$816 million contract from the U.S. Space Development Agency to build 18 missile defense satellites, while also facing setbacks tied to NASA funding and Neutron testing.

Recent price action reflects that tension between opportunity and risk, with a 1 day share price decline of 9.29% and a 30 day share price decline of 21.12%. This comes even as the 1 year total shareholder return is 141.96% and the 5 year total shareholder return is more than 5x, suggesting long term holders have seen very large gains while near term momentum has cooled on contract uncertainty and Neutron testing issues.

If this mix of contract wins and setbacks has you looking more broadly at space related opportunities, it could be worth checking out 28 robotics and automation stocks as a starting point for other ideas in adjacent technology.

With the stock down 21.12% over 30 days but still showing a very large 5-year total return, and trading at an implied 15% intrinsic discount plus 26.6% below the average analyst target, is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 32.2% Undervalued

According to the most followed narrative on Rocket Lab, a fair value of $97.83 sits well above the last close at $66.32. This puts that recent pullback in a very different light.

Neutron's successful operation should be that turning point, but Neutron's failure would risk the entire company. Rocket Lab's biggest risk is the difficulty of space flight and the challenge of managing working capital and the expectations of early customers, until sufficient scale can be achieved to cement space flight and Rocket Lab's role as an everyday part of the global economy.

Want to see why this narrative points to a much higher price? It leans on rapid revenue expansion, rising margins and a future earnings multiple usually reserved for mature market leaders. Curious which assumptions carry the most weight in that $97.83 fair value? The full narrative lays out the numbers driving that call.

Result: Fair Value of $97.83 (UNDERVALUED)

However, this story still depends on Neutron reaching commercial use and Rocket Lab turning its US$197.632 million net loss into sustainable profitability before funding conditions tighten again.

Another View on Value

That 32.2% discount to a $97.83 fair value leans heavily on long term growth assumptions, but the market is also sending a different signal. On a P/B of 27.7x versus 10.2x for peers and 3.8x for the wider Aerospace & Defense group, the shares look expensive on balance sheet terms. This raises the question of how much optimism is already embedded.

Build Your Own Rocket Lab Narrative

If you see the numbers differently or just prefer to run your own checks, you can pull together a personalized Rocket Lab story in a few minutes: Do it your way.

A great starting point for your Rocket Lab research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Rocket Lab has sparked your interest, do not stop here. Give yourself options by lining up a few more ideas that match your style and risk comfort.

• Spot potential bargains quickly by scanning our list of 55 high quality undervalued stocks that pair quality fundamentals with prices the market might be overlooking.
• Strengthen the defensive side of your holdings by reviewing a solid balance sheet and fundamentals stocks screener (46 results) that can help you focus on companies with sturdier financial footing.
• Get ahead of the crowd by searching through a screener containing 25 high quality undiscovered gems that highlights under followed names with stronger numbers than attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.